The latest report from SDi examines the bioprocessing market which they project will grow at a compound annual growth rate (CAGR) of 9.0% during the next five years. The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. […]
The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.
